| Trial ID: | L5146 |
| Source ID: | NCT06141590
|
| Associated Drug: |
Administration Of Ui068
|
| Title: |
A Clinical Study to Evaluate the Safety and the Pharmacokinetics of UI068 in Healthy Adult Volunteers Under Fed Conditions
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: administration of UI068|DRUG: administration of UIC202205, UIC202206
|
| Outcome Measures: |
Primary: AUCt, Evaluation PK for Linagliptin and Metformin after single dose, 0 to 72hr|Cmax, Evaluation PK for Linagliptin and Metformin after single dose, 0 to 72hr |
|
| Sponsor/Collaborators: |
Sponsor: Korea United Pharm. Inc.
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE1
|
| Enrollment: |
35
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2023-03-11
|
| Completion Date: |
2023-08-29
|
| Results First Posted: |
|
| Last Update Posted: |
2023-11-21
|
| Locations: |
H plus Yangji Hospital, Seoul, Gwanak-gu, 08779, Korea, Republic of
|
| URL: |
https://clinicaltrials.gov/show/NCT06141590
|
